How are factor VIII and factor IX replacement used to treat hemophilia?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

To treat hemophilia, medical management focuses on replacing the specific missing coagulation factor to restore the blood's ability to clot.12

Treatment Methods

  • Infusion Therapy: For hemophilia A, factor VIII is replaced via intravenous infusion of plasma from normal donors, cryoprecipitate, or purified factor VIII preparations. Similarly, hemophilia B is treated by infusing factor IX derived from normal plasma.32
  • Recombinant Technology: Modern medicine utilizes recombinant DNA technology to produce safer, synthetic versions of these proteins, reducing risks associated with human-derived blood products.12
  • Adjunctive Therapies: In milder cases of hemophilia A, the drug desmopressin (DDAVP) may be used to help manage bleeding. Additionally, gene therapy has shown effectiveness in addressing the underlying factor IX deficiency in hemophilia B.12

By administering the missing protein, patients can effectively manage bleeding episodes and undergo necessary surgical procedures, allowing them to lead productive lives.2